Volition

Volition company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics. Our mission is to save lives and improve outcomes for millions of people and animals worldwide. Imagine a world where diseases like cancer and sepsis can be diagnosed early and monitored easily using routine blood tests. That’s the world we’re trying to build by developing our innovative family of simple, easy to use, cost-effective tests. Our patented technologies use chromosomal structures such as nucleosomes and transcription factors as biomarkers in cancer and other diseases. All the tests in our portfolio detect various characteristic changes that occur from the earliest stages of disease, enabling early detection and potentially a better way to monitor disease progression and a patient’s response to treatment. Our ground breaking nucleosome quantification technology is currently being used for cancer applications in veterinary medicine and we are continuing to expand our technology in human medicine through early clinical trials in cancer, sepsis and beyond. Regarding our Nu.Q® technology, we have four pillars of focus: Nu.Q® Vet, Nu.Q® NETs, Nu.Q® Discover and Nu.Q® Cancer. We have also developed Capture-PCR™, a novel method for liquid biopsy enabling rapid, cost-effective cancer detection in a routine blood test. We are headquartered in Henderson, Nevada with locations in Belgium, California, Singapore and the UK. We are listed on the New York Stock Exchange (NYSE AMERICAN) as VolitionRX Limited (VNRX).

Company Details

Employees
86
Founded
-
Address
1489 W Warm Springs Rd, Henderson,nevada 89014,united States
Phone
202-618-1750
Email
in****@****nrx.com
Industry
Biotechnology
HQ
Henderson, Nevada
Looking for a particular Volition employee's phone or email?

Volition Questions

News

VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants - Yahoo Finance

VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants Yahoo Finance

$6.0M Gross Proceeds — VolitionRx Prices 11.55M Shares & Warrants; Close Expected Oct 14, 2025 - Stock Titan

$6.0M Gross Proceeds — VolitionRx Prices 11.55M Shares & Warrants; Close Expected Oct 14, 2025 Stock Titan

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update - PR Newswire

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update PR Newswire

How VolitionRx Limited stock benefits from strong dollar - July 2025 Spike Watch & Community Consensus Stock Picks - Trung tâm Dự báo KTTV quốc gia

How VolitionRx Limited stock benefits from strong dollar - July 2025 Spike Watch & Community Consensus Stock Picks Trung tâm Dự báo KTTV quốc gia

VolitionRX stock holds steady as Benchmark reiterates rating - Investing.com

VolitionRX stock holds steady as Benchmark reiterates rating Investing.com

HC Wainwright & Co. Initiates Coverage of VolitionRx (VNRX) with Buy Recommendation - Nasdaq

HC Wainwright & Co. Initiates Coverage of VolitionRx (VNRX) with Buy Recommendation Nasdaq

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering - 富途牛牛

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering 富途牛牛

15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants - Stock Titan

15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants Stock Titan

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update - Yahoo Finance

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update Yahoo Finance

Is VolitionRx Limited stock a buy before product launches - July 2025 Setups & Smart Swing Trading Alerts - Trung tâm Dự báo KTTV quốc gia

Is VolitionRx Limited stock a buy before product launches - July 2025 Setups & Smart Swing Trading Alerts Trung tâm Dự báo KTTV quốc gia

VolitionRX stock rating reiterated at Buy by H.C. Wainwright - Investing.com

VolitionRX stock rating reiterated at Buy by H.C. Wainwright Investing.com

VolitionRX Ltd (VNRX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances ... - Yahoo Finance

VolitionRX Ltd (VNRX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances ... Yahoo Finance

Volition's Nu.Q Platform Gains Traction: Revenue Up 15% as Multiple Licensing Deals Near Completion - Stock Titan

Volition's Nu.Q Platform Gains Traction: Revenue Up 15% as Multiple Licensing Deals Near Completion Stock Titan

VolitionRx Management Shows Confidence: Joins $1.2M Direct Offering with Warrant Sweetener - Stock Titan

VolitionRx Management Shows Confidence: Joins $1.2M Direct Offering with Warrant Sweetener Stock Titan

VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones - Yahoo Finance

VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones Yahoo Finance

VolitionRx prices $6 million public offering of common stock and warrants - Investing.com

VolitionRx prices $6 million public offering of common stock and warrants Investing.com

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast - Investing.com

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast Investing.com

Earnings call transcript: VolitionRx Q2 2025 sees revenue rise, stock dips - Investing.com

Earnings call transcript: VolitionRx Q2 2025 sees revenue rise, stock dips Investing.com

Still buys VolitionRx (VNRX) shares and warrants for $24,518 - Investing.com

Still buys VolitionRx (VNRX) shares and warrants for $24,518 Investing.com

H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 - Investing.com

H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 Investing.com

Volitionrx CEO Reynolds buys $9,885 in company stock - Investing.com

Volitionrx CEO Reynolds buys $9,885 in company stock Investing.com

VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus

VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants GuruFocus

How VolitionRX Limited stock reacts to Fed tightening - Insider Buying & Technical Analysis for Trade Confirmation - Trung tâm Dự báo KTTV quốc gia

How VolitionRX Limited stock reacts to Fed tightening - Insider Buying & Technical Analysis for Trade Confirmation Trung tâm Dự báo KTTV quốc gia

Why analysts remain bullish on VolitionRx Limited stock - Bear Alert & Weekly High Conviction Trade Ideas - Trung tâm Dự báo KTTV quốc gia

Why analysts remain bullish on VolitionRx Limited stock - Bear Alert & Weekly High Conviction Trade Ideas Trung tâm Dự báo KTTV quốc gia

H.C. Wainwright Maintains VolitionRX(VNRX.US) With Buy Rating, Maintains Target Price $2.5 - 富途牛牛

H.C. Wainwright Maintains VolitionRX(VNRX.US) With Buy Rating, Maintains Target Price $2.5 富途牛牛

Volitionrx Limited announces proposed underwritten public offering of common stock - MarketScreener

Volitionrx Limited announces proposed underwritten public offering of common stock MarketScreener

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Stock Titan

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV Stock Titan

Why VolitionRx Limited stock is considered a top pick - 2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Fundação Cultural do Pará

Why VolitionRx Limited stock is considered a top pick - 2025 Buyback Activity & Free Real-Time Market Sentiment Alerts Fundação Cultural do Pará

Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com Canada

Volitionrx stock tumbles on proposed public offering By Investing.com Investing.com Canada

How VolitionRx Limited stock benefits from strong dollar - Portfolio Update Report & Capital Efficient Trading Techniques - Fundação Cultural do Pará

How VolitionRx Limited stock benefits from strong dollar - Portfolio Update Report & Capital Efficient Trading Techniques Fundação Cultural do Pará

VolitionRX (VNRX) Stock Price, News & Analysis - MarketBeat

VolitionRX (VNRX) Stock Price, News & Analysis MarketBeat

VolitionRx (VNRX) Stock Price, News & Analysis - MarketBeat

VolitionRx (VNRX) Stock Price, News & Analysis MarketBeat

VNRX Stock Price and Chart — AMEX:VNRX - TradingView

VNRX Stock Price and Chart — AMEX:VNRX TradingView

InvestmentPitch Media Invites Investors to the GCFF Conference in Toronto on September 30, 2017 - Video Hosted on InvestmentPitch.com - Newsfile

InvestmentPitch Media Invites Investors to the GCFF Conference in Toronto on September 30, 2017 - Video Hosted on InvestmentPitch.com Newsfile

VolitionRx diagnostic test validated by blood stability - Proactive financial news

VolitionRx diagnostic test validated by blood stability Proactive financial news

Mr Cameron Reynolds, VolitionRx: Patient awareness & demand will fuel diagnostics in 2013 - BioSpectrum Asia

Mr Cameron Reynolds, VolitionRx: Patient awareness & demand will fuel diagnostics in 2013 BioSpectrum Asia

Top Volition Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant